DISCLAIMER
The information and materials accessed through or made available for use on any of our Sites, including, any information about diseases, conditions, treatments, or medicines, are for informational purposes only. The Content is not intended to be and is not a substitute for professional medical advice, diagnosis, or treatment, and your participation on our Sites does not create a healthcare professional-patient relationship. You should consult a doctor or other qualified health care professional regarding any questions you have about your health or before making any decisions related to your health or wellness. Call your doctor or 911 immediately if you think you may have a medical emergency.compose your message
message sent
email sent successfully
Trusted Resources: News & Events
Latest announcements and gatherings
Serious Gum Disease With Sickle Cell May Lead to Repeat Pain Crises
People with sickle cell anemia are at a significantly higher risk of developing periodontitis, a serious gum disease, a study reported. In turn, periodontitis was associated with elevated levels of inflammation markers in patients and a three times greater chance of more than three painful vaso-occlusive crises (VOCs) each year. These findings highlight the importance of “setting of a strict periodontal screening program for this special patient population and the control/reduction of periodontal inflammation,” its researchers wrote.
The study, “Association between periodontal inflamed surface area and serum acute phase biomarkers in patients with sickle cell anemia,” was published in the journal Archives of Oral Biology. Sickle cell anemia, the most common form of sickle cell disease, and often its most severe form, has been associated with an increased release of inflammatory molecules called cytokines. This cytokine production perpetuates a chronic inflammatory state that can lead to the development of other diseases, including those affecting the gums.
Related Content
-
people & placesJohns Hopkins Berman Institute of BioethicsEstablished in 1995, the Berman Institut...
-
news & eventsKids Who Need Sickle Cell Meds Don’t Always Get ThemLess than a fifth of U.S. children with ...
-
news & eventsGene Therapy for Blood DisordersIn the context of intense scrutiny over ...
-
news & eventsPCORI Board Approves $18 Million for Research on Sickle Cell DiseaseThe Patient-Centered Outcomes Research I...
-
education & researchVaso-Occlusive Crises and Costs of Sickle Cell Disease in Patients With Commercial, Medicaid and Medicare Insurance ...Aim: To characterize vaso-occlusive cri...
-
people & placesBrenda Martin, CPNP-PCBrenda Martin is a pediatric nurse pract...
-
education & researchNitric Oxide, Phosphodiesterase Inhibitors and Soluble Guanylate Cyclase Stimulators as Candidate Treatments for Sic...Despite being described in the medical l...
send a message
To improve your experience on this site, we use cookies. This includes cookies essential for the basic functioning of our website, cookies for analytics purposes, and cookies enabling us to personalize site content. By clicking on 'Accept' or any content on this site, you agree that cookies can be placed. You may adjust your browser's cookie settings to suit your preferences. More Information
The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.
Support for this site is provided by
This platform is made possible through a partnership with the Sickle Cell Disease Association of America, Inc. (SCDAA) and its member organizations. SCDAA's mission is to advocate for people affected by sickle cell conditions and empower community-based organizations to maximize quality of life and raise public consciousness while advancing the search for a universal cure.